TY - JOUR
T1 - Willingness to pay for a quality-adjusted life year
T2 - Implications for societal health care resource allocation
AU - King, Joseph T.
AU - Tsevat, Joel
AU - Lave, Judith R.
AU - Roberts, Mark S.
PY - 2005/11
Y1 - 2005/11
N2 - Background. Health-state preferences can be combined with willingness-to-pay (WTP) data to calculate WTP per quality-adjusted life year (QALY). The WTP/QALY ratios provide insight into societal valuations of expenditures for medical interventions. Methods. The authors measured preferences for current health in 3 patient populations (N = 391) using standard gamble, time trade-off, visual analog scale, and WTP, then they calculated WTP/QALY ratios. The ratios were compared with several proposed cost/QALY cost-effectiveness ratio thresholds, the value-of-life literature, and with WTP/ QALY ratios derived from published preference research. Results. Mean WTP/QALY ratios ranged from $12,500 to $32,200 (2003 $US). All values were below most published cost-effectiveness ratio thresholds, below the ratio from a prototypic medical treatment covered by Medicare (i.e., renal dialysis), and below ratios from the value-of-life literature. The WTP/QALY ratios were similar to those calculated from published preference data for patients with symptomatic menopause, dentofacial deformities, asthma, or dermatologic disorders. Conclusions. WTP/QALY ratios calculated using preference data collected from diverse populations are lower than most proposed thresholds for determining what is "cost-effective." Current proposed cost-effectiveness ratio thresholds may overestimate the willingness of society to pay for medical interventions.
AB - Background. Health-state preferences can be combined with willingness-to-pay (WTP) data to calculate WTP per quality-adjusted life year (QALY). The WTP/QALY ratios provide insight into societal valuations of expenditures for medical interventions. Methods. The authors measured preferences for current health in 3 patient populations (N = 391) using standard gamble, time trade-off, visual analog scale, and WTP, then they calculated WTP/QALY ratios. The ratios were compared with several proposed cost/QALY cost-effectiveness ratio thresholds, the value-of-life literature, and with WTP/ QALY ratios derived from published preference research. Results. Mean WTP/QALY ratios ranged from $12,500 to $32,200 (2003 $US). All values were below most published cost-effectiveness ratio thresholds, below the ratio from a prototypic medical treatment covered by Medicare (i.e., renal dialysis), and below ratios from the value-of-life literature. The WTP/QALY ratios were similar to those calculated from published preference data for patients with symptomatic menopause, dentofacial deformities, asthma, or dermatologic disorders. Conclusions. WTP/QALY ratios calculated using preference data collected from diverse populations are lower than most proposed thresholds for determining what is "cost-effective." Current proposed cost-effectiveness ratio thresholds may overestimate the willingness of society to pay for medical interventions.
KW - Cost-effectiveness analysis
KW - Preferences
KW - QALYs
KW - Utility
KW - Willingness to pay
UR - http://www.scopus.com/inward/record.url?scp=27944464408&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=27944464408&partnerID=8YFLogxK
U2 - 10.1177/0272989X05282640
DO - 10.1177/0272989X05282640
M3 - Article
C2 - 16282217
AN - SCOPUS:27944464408
SN - 0272-989X
VL - 25
SP - 667
EP - 677
JO - Medical Decision Making
JF - Medical Decision Making
IS - 6
ER -